MRI study for people with anoctamin-5 muscle gene changes
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This trial uses MRI scans of your lower back and leg muscles to better understand how anoctamin-5 gene changes affect muscle structure. It may help researchers learn patterns that could improve future care, and you would be expected to have specific genetic results and a scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have two known harmful (pathogenic) changes in the anoctamin-5 gene
- You can have MRI pictures taken of your lower back and leg muscles using a specific MRI type
- You do not have another medical condition that could also cause muscle wasting (atrophy)
- You have not recently spent a long time in intensive care that could affect muscles
- You likely need genetic testing results that clearly show the two anoctamin-5 changes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
This study tests whether special MRI scans can help evaluate neuromuscular (muscle/nerve) diseases. It may help doctors better assess muscle involvement and support diagnosis and evaluation.
This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.
This study looks at how specific gene changes relate to the pattern of muscle weakness in people with limb-girdle muscular dystrophy (LGMD). It may help doctors better understand the condition and improve future care.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study uses artificial intelligence to analyze muscle MRI scans in people with genetically confirmed neuromuscular diseases. It aims to improve how these conditions are diagnosed and tracked.
Hear when a new Limb Girdle Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.